Mustang Bio inc (MBIO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MBIO Annual Balance Sheets →
A period-by-period view of the balance sheet from Mustang Bio inc to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent15.15
Cash & Short-term Investments15.00
Other Receivables, Net, Current0.22
Prepaid Expense And Other Assets Current0.25
Total Current Assets15.61
Property Plant And Equipment Excluding Assets Under Construction-
Restricted Cash Noncurrent-
Operating Lease Right Of Use Asset-
Total Assets15.61
Liabilities
Accounts Payable and Accrued Liabilities, Current LI5.38
Accrued Liabilities, Current1.58
Other Liabilities, Current0.96
Total Current Liabilities7.92
Total Long-term Debt0.00
Accrued Rent, Noncurrent0.15
OperatingLeaseLiabilityNoncurrent-
Operating Lease Liability Current-
Deferred Income Noncurrent0.15
Total Liabilities8.07
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock408.22
Retained Earnings / Accumulated Deficit-400.67
Other Equity0.00
Common Stockholder's Equity7.55
Total Stockholder's Equity7.55
Liabilities & Stockholder's Equity15.61
4 historic quarters locked

Sign in to unlock the full Mustang Bio inc balance sheet history.

About Mustang Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-091061

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.